…
Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. The company was incorporated in 2018 and is based in London, United Kingdom.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Income before tax | -5.99M | -3.33M | -0.33M | -0.08M |
| Net income | -5.99M | -3.33M | -0.33M | -0.08M |
| Selling general administrative | 2.68M | 1.08M | 0.21M | 0.07M |
| Selling and marketing expenses | 1.93M | 0.83M | - | - |
| Gross profit | 0.02M | - | - | - |
| Ebit | -5.99M | -3.33M | -0.33M | -0.08M |
| Ebitda | -5.99M | -3.33M | -0.33M | -0.07M |
| Depreciation and amortization | 0.00M | 0.00M | 0.00M | 0.01M |
| Operating income | -5.99M | -3.33M | -0.33M | -0.08M |
| Other operating expenses | 6.02M | 3.33M | 0.33M | 0.07M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.00M | 0.00M | 0.00M | 0.00M |
| Net interest income | 0.00M | 0.00M | 0.00M | 0.00M |
| Income tax expense | -0.00M | -0.00M | -0.00M | -0.00M |
| Total revenue | 0.03M | 0.00M | 0.00M | 0.00M |
| Total operating expenses | 6.01M | 3.33M | 0.33M | 0.07M |
| Cost of revenue | 0.01M | - | - | - |
| Total other income expense net | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income from continuing ops | -5.99M | -3.33M | -0.33M | -0.08M |
| Net income applicable to common shares | -5.99M | -3.33M | -0.33M | -0.08M |
| Breakdown | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Total assets | 5.13M | 10.75M | 0.10M | 0.08M |
| Other current assets | 0.25M | 0.37M | 0.09M | 0.08M |
| Total liab | 0.28M | 0.20M | 0.18M | 0.03M |
| Total stockholder equity | 4.85M | 10.55M | -0.08M | 0.06M |
| Other current liab | 0.15M | 0.02M | 0.18M | 0.03M |
| Common stock | 0.51M | 0.50M | 0.13M | 0.10M |
| Capital stock | 0.51M | 0.50M | 0.13M | 0.10M |
| Retained earnings | -9.73M | -3.74M | -0.41M | -0.08M |
| Cash | 4.38M | 10.32M | 0.01M | 0.00M |
| Total current liabilities | 0.28M | 0.20M | 0.18M | 0.03M |
| Net debt | -4.38M | -10.32M | -0.01M | -0.00M |
| Other stockholder equity | 14.08M | 13.78M | 0.20M | 0.03M |
| Total current assets | 5.13M | 10.75M | 0.10M | 0.08M |
| Net tangible assets | 4.85M | 10.55M | -0.08M | 0.06M |
| Net receivables | 0.10M | 0.21M | 0.01M | 0.08M |
| Inventory | 0.50M | 0.06M | - | - |
| Accounts payable | 0.13M | 0.18M | - | - |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 |
| Investments | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to liabilities | 0.08M | 0.02M | 0.16M | 0.03M |
| Total cashflows from investing activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Total cash from financing activities | 0.03M | 13.06M | 0.19M | 0.06M |
| Net income | -5.99M | -3.33M | -0.33M | -0.08M |
| Change in cash | -5.95M | 10.31M | 0.00M | 0.00M |
| Begin period cash flow | 10.32M | 0.01M | 0.00M | 0.00M |
| End period cash flow | 4.38M | 10.32M | 0.01M | 0.00M |
| Total cash from operating activities | -5.97M | -2.75M | -0.19M | -0.05M |
| Issuance of capital stock | 0.03M | 13.06M | 0.19M | 0.06M |
| Other cashflows from investing activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | -0.45M | -0.06M | -0.06M | -0.06M |
| Change to account receivables | 0.12M | -0.28M | -0.01M | -0.00M |
| Sale purchase of stock | - | 13.06M | 0.19M | 0.06M |
| Other cashflows from financing activities | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to netincome | 0.27M | 0.90M | -0.00M | -0.00M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -0.25M | -0.32M | 0.14M | 0.02M |
| Stock based compensation | 0.27M | 0.91M | - | - |
| Other non cash items | -0.00M | -0.00M | -0.00M | -0.00M |
| Free cash flow | -5.97M | -2.75M | -0.19M | -0.05M |
Sector: Consumer Defensive Industry: Household & Personal Products
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ULVR Unilever PLC |
-30.50 0.62% |
4892.50 | 19.06 | 15.41 | 1.86 | 6.73 | 2.51 | 11.39 |
| RKT Reckitt Benckiser Group PLC |
-266.00 4.85% |
5218.00 | 10.71 | 15.13 | 2.37 | 4.31 | 2.82 | 8.41 |
| PZC PZ Cussons PLC |
-0.60 0.63% |
95.00 | - | 9.64 | 0.63 | 1.42 | 0.81 | 7.05 |
| TBTG The Beauty Tech Group PLC |
1.00 0.21% |
487.00 | 54.42 | 10.70 | 2.67 | 598.72 | 3.11 | 14.60 |
Cellular Goods PLC, together with its subsidiaries, manufactures and sells biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online. The company was formerly known as Leaf Studios PLC and changed its name to Cellular Goods PLC in September 2020. The company was incorporated in 2018 and is based in London, United Kingdom.
16 Great Queen Street, London, United Kingdom, WC2B 5DG
44 20 7031 6871
5
| Name | Title | Year Born |
|---|---|---|
| Ms. Alexia Blake | Head of Research & Product Devel. | NA |
| Mr. Alexis Abraham | Chief Strategy Officer & Director | 1982 |
| Ms. Anna Chokina | Chief Exec. Officer | NA |
| Ms. Bruna Nikolla | CFO, Company Sec. & Director | NA |
| Neil Thapar | Investor Relations | NA |
| Sean O'Dwyer | Marketing Director | NA |
| Mr. Istok Nahtigal | Head of Process & Applied Sciences | NA |
| Mr. Nikhil Vijayan | Chief Supply Chain Officer | NA |
| Jodie Sanders | Commercial & Partnerships Director | NA |
| Mr. Anthony Buck | Skincare Adviser | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.